参考文献/References:
[1] SMYTH E C,NILSSON M,GRABSCH H I,et al.Gastric cancer[J].Lancet,2020,396(10251):635-648.
[2] LEWIS B P,BURGE C B,BARTEL D P.Conserved seed pairing,often flanked by adenosines,indicates that thousands of human genes are microRNA targets[J].Cell,2005,120(1):15-20.
[3] ZHENG J,LIU Y,QIAO Y,et al.miR-103 promotes proliferation and metastasis by targeting KLF4 in gastric cancer[J].Int J Mol Sci,2017,18(5):910.
[4] HU X,MIAO J,ZHANG M,et al.miRNA-103a-3p promotes human gastric cancer cell proliferation by targeting and suppressing ATF7 in vitro[J].Mol Cells,2018,41(5):390-400.
[5] LIU Y,LI L,LIU Y,et al.RECK inhibits cervical cancer cell migration and invasion by promoting p53 signaling pathway[J].J Cell Biochem,2018,119(4):3058-3066.
[6] XU M,WANG H F,ZHANG H Z.Expression of RECK and MMPs in hepatoblastoma and neuroblastoma and comparative analysis on the tumor metastasis[J].Asian Pac J Cancer Prev,2015,16(9):4007-4011.
[7] CLARK J C,THOMAS D M,CHOONG P F,et al.RECK:a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer[J].Cancer Metastasis Rev,2007,26(3/4):675-683.
[8] BRAY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
[9] CHEN L P,ZHANG N N,REN X Q,et al.miR-103/miR-195/miR-15b regulate SALL4 and inhibit proliferation and migration in glioma[J].Molecules,2018,23(11):2938.
[10] GE J,MAO L,XU W,et al.miR-103a-3p suppresses cell proliferation and invasion by targeting tumor protein D52 in prostate cancer[J].J Invest Surg,2021,34(9):984-992.
[11] ZHANG M L,SUN W H,WU H Q,et al.Knockdown of microRNA-103a-3p inhibits the malignancy of thyroid cancer cells through Hippo signaling pathway by upregulating LATS1[J].Neoplasma,2020,67(6):1266-1278.
[12] FU M,CHEN C W,YANG L Q,et al.MicroRNA-103a-3p promotes metastasis by targeting TPD52 in salivary adenoid cystic carcinoma[J].Int J Oncol,2020,57(2):574-586.
[13] LI H,HUHE M,LOU J.MicroRNA-103a-3p promotes cell proliferation and invasion in non-small-cell lung cancer cells through Akt pathway by targeting PTEN[J].Biomed Res Int,2021,2021:7590976.
[14] ZHU X,LIU D,WANG Y,et al.Salidroside suppresses nonsmall cell lung cancer cells proliferation and migration via microRNA-103-3p/Mzb1[J].Anticancer Drugs,2020,31(7):663-671.
[15] LIANG J,LIU X,XUE H,et al.MicroRNA-103a inhibits gastric cancer cell proliferation,migration and invasion by targeting c-Myb[J].Cell Prolif,2015,48(1):78-85.
[16] SHRESTHA S,HSU S D,HUANG W Y,et al.A systematic review of microRNA expression profiling studies in human gastric cancer[J].Cancer Med,2014,3(4):878-888.
[17] KIM B H,HONG S W,KIM A,et al.Prognostic implications for high expression of oncogenic microRNAs in advanced gastric carcinoma[J].J Surg Oncol,2013,107(5):505-510.
[18] 孟宁,周谦,赵静,等.肝细胞生长因子及RECK在胃癌组织中的表达及临床意义[J].疑难病杂志,2020,19(11):1115-1118,1124.
MENG N,ZHOU Q,ZHAO J,et al.The expression and clinical significance of hepatocyte growth factor and RECK in gastric cancer[J].Chin J Difficult Compl Cases,2020,19(11):1115-1118,1124.
[19] HAN T S,VOON D C,OSHIMA H,et al.Interleukin 1 up-regulates MicroRNA 135b to promote inflammation-associated gastric carcinogenesis in mice[J].Gastroenterology,2019,156(4):1140-1155.e4.
[20] LIU W,SONG N,YAO H,et al.MiR-221 and miR-222 simultaneously target RECK and regulate growth and invasion of gastric cancer cells[J].Med Sci Monit,2015,21:2718-2725.
[21] XIE J,TAN Z H,TANG X,et al.MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis[J].World J Gastroenterol,2014,20(46):17439-17447.
[22] ZHAO H,WANG Y,YANG L,et al.MiR-25 promotes gastric cancer cells growth and motility by targeting RECK[J].Mol Cell Biochem,2014,385(1-2):207-213.
[23] SHEN B,YU S,ZHANG Y,et al.MiR-590-5p regulates gastric cancer cell growth and chemosensitivity through RECK and the AKT/ERK pathway[J].Onco Targets Ther,2016,9:6009-6019.
相似文献/References:
[1]陈赜,陈杰,严想元,等.腹腔镜辅助胃癌根治术治疗早期胃癌疗效观察[J].新乡医学院学报,,():000.
[2]于成功,萧树东,赵宪邨,等.胃癌胃良性病变患者血清和局部组织中IL—I水平及意义[J].新乡医学院学报,1996,13(03):220.
[3]王淑秀,赵卫星,和瑞芝,等.P~(53)和rasP~(21)在胃癌中表达的免疫组化研究[J].新乡医学院学报,1997,14(02):137.
[4]赵卫星,王淑秀,卢朝晖,等.幽门螺杆菌与胃癌基因抑癌基因突变的关系[J].新乡医学院学报,1997,14(03):203.
[5]王淑秀.抑癌基因和癌基因与胃癌[J].新乡医学院学报,1997,14(01):083.
[6]冯艳玲,乐晓萍,蔡新华.胃癌患者P16和P53蛋白的表达及其相互关系[J].新乡医学院学报,2000,17(06):403.
[7]周玲生.纤维胃镜粘膜活检1356 例病理分析[J].新乡医学院学报,2000,17(06):462.
[8]任金萍,王淑秀,付华民,等.青年与老年人胃癌中PCNA和AgNOR计数表达的对比研究[J].新乡医学院学报,2000,17(03):156.
[9]贾文英,张合喜,马彦民.幽门螺杆菌感染与胃癌关系的Meta 分析[J].新乡医学院学报,2000,17(05):328.
[10]窦天伟,刘 炯,罗志勇,等.复发胃癌再次手术42例疗效和随访结果[J].新乡医学院学报,2003,20(05):337.